San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

 

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Avatar

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

By San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians FEATURING Barry Greenberg
By San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians FEATURING Barry Greenberg
2,016 views
February 5, 2021
Comments 0
Login to view comments. Click here to Login
SESSION II - Cardiac Hypertrophy, Amyloid and Other Infiltrative Diseases
17:43

Advances in Diagnosis and Treatment of Hypertrophic Cardiomyopathy: …

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

J. Silva Enciso

455 views
18:37

Diagnosing and Treating 73 y/o Patient with Benign Murmur in the Pas…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

M. Urey, B. Greenberg, J. Silva Enciso

11 views
16:36

Advances in the Diagnosis and Management of Amyloid Disease: What Do…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

M. Urey

48 views
17:35

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg

2.0K views